Thomas Okarma gave the keynote address at the 2010 World Stem Cell Summit. He spoke about his company’s research and future plans for treating those with spinal injuries. The Geron Corporation had received permission from the FDA to begin the world’s first human clinical trial to test embryonic stem cells as a treatment for spinal cord injuries.
Recent Posts
- CAR NK cell therapy clinical trial puts follicular lymphoma survivor into remission
- Stem cell therapy linked to lower risk of heart failure after a heart attack
- Embryo-Like ‘Blood Factories’ Could One Day Supplement Donations
- Long-Term Growth Hormone Therapy Boosts Pediatric Stem Cells
- New UCLA drug could restore heart and organ function
- Parkinson’s treatment tested at UW showing promise in first clinical trial
